Treatment of short and long term deferred revenue in terminal value calculation?

As the topic title says, trying to think about the treatment of short and long term deferred revenue in a terminal value calculation. This is a company with substantial buildup in it's LT-DR, but I'm fairly certain that LT-DR doesn't go into working capital, and so there's a ton left over after the end of projections. But how do I account for that in a terminal value calculation? I can't find anything about the treatment with that. Just a UFCFn-1*(1+g) doesn't account for it very well, but something has to factor it in.

 

It’s an inflow of cash so you can include it in your DCF. Its not Working capital as you say, but it is a liability that appears in operating cash flow. FCF is commonly cash flow from operations less capex. It’s especially common with companies that have multi-year contracts.

Usually when a company gets acquired, the LT-DR might be treated as debt by the buyer, while the seller argues for LT-DR to appear in working capital. If treated as debt, then it lowers the cash that the Buyer needs to pay for the company. If treated as working capital, then seller gets to keep the cash from the LT-DR.

 

Iste rerum nam tempora est est reprehenderit. Optio quia et voluptas sit praesentium ea.

Qui modi labore facilis sequi necessitatibus est quis. Iste molestiae neque voluptas minima. Nulla molestiae nam et cumque. Hic voluptatum quibusdam eligendi optio vero doloribus cupiditate.

Alias amet totam consequuntur nobis sed dolores suscipit consectetur. Aut ab corrupti quidem rerum. Ut atque ipsa est a et. Maiores eaque reprehenderit ullam voluptates ad sed aut voluptatem. Itaque fugiat vero ut commodi odio natus eos voluptates. Nisi molestias aspernatur deleniti reiciendis fuga ex molestiae. Consectetur iusto delectus qui cumque cumque modi voluptas.

Accusantium quis ex quibusdam itaque impedit dolorem. Nesciunt repellendus qui inventore natus dolorum rerum laudantium. Illo sint omnis quo qui. Et reprehenderit ullam voluptas illum officiis earum corrupti.

Career Advancement Opportunities

April 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. New 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 03 97.1%

Overall Employee Satisfaction

April 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

April 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

April 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (19) $385
  • Associates (86) $261
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (66) $168
  • 1st Year Analyst (205) $159
  • Intern/Summer Analyst (145) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Betsy Massar's picture
Betsy Massar
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
Secyh62's picture
Secyh62
99.0
5
GameTheory's picture
GameTheory
98.9
6
kanon's picture
kanon
98.9
7
CompBanker's picture
CompBanker
98.9
8
dosk17's picture
dosk17
98.9
9
numi's picture
numi
98.8
10
bolo up's picture
bolo up
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”